Yoon Ki Kim

Chief Technology Officer & Professor RiboTech & Korea Advanced Institute of Science and Technology

Yoon Ki Kim’s primary research focuses on the molecular mechanisms of mRNA decay, translation, and mRNA modifications that regulate gene expression.

Seminars

Tuesday 21st July 2026
Harnessing Lariat-Capping to Improve the Stability & Therapeutic Efficacy of mRNA & Self-Amplifying RNA
12:30 pm
  • 5’ lariat-cap (LC) structure stabilizes mRNA
  • Lariat-capped (LC) mRNAs and LC saRNAs show higher protein expression than a conventional clean‑capped counterparts
  • Showcasing SARS‑CoV‑2 vaccines with LC saRNA induce strong neutralizing antibodies
Yoon Ki Kim - 6th mRNA-Based Therapeutics Summit Speaker